|
1
|
Tan CS, Gilligan D and Pacey S: Treatment
approaches for EGFR-inhibitor-resistant patients with
non-small-cell lung cancer. Lancet Oncol. 16:e447–e459. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhong WZ, Zhou Q and Wu YL: The resistance
mechanisms and treatment strategies for EGFR-mutant advanced
non-small-cell lung cancer. Oncotarget. 8:71358–71370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calvayrac O, Mazieres J, Figarol S,
Marty-Detraves C, Raymond-Letron I, Bousquet E, Farella M,
Clermont-Taranchon E, Milia J, Rouquette I, et al: The RAS-related
GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors
in non-small-cell lung cancer via an AKT-dependent mechanism. EMBO
Mol Med. 9:238–250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang L and Fu L: Mechanisms of resistance
to EGFR tyrosine kinase inhibitors. Acta Pharm Sin B. 5:390–401.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moreira JB, Wohlwend M, Alves MN, Wisløff
U and Bye A: A small molecule activator of AKT does not reduce
ischemic injury of the rat heart. J Transl Med. 13:762015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sordella R, Bell DW, Haber DA and
Settleman J: Gefitinib-sensitizing EGFR mutations in lung cancer
activate anti-apoptotic pathways. Science. 305:1163–1167. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Camilo R, Capelozzi VL, Siqueira SA and
Del Carlo Bernardi F: Expression of p63, keratin 5/6, keratin 7,
and surfactant-A in non-small cell lung carcinomas. Hum Pathol.
37:542–546. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ho WC, Pikor L, Gao Y, Elliott BE and
Greer PA: Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling
pathway in mammary carcinoma. J Biol Chem. 287:15458–15465. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li P, Miao C, Liang C, Shao P, Wang Z and
Li J: Silencing CAPN2 expression inhibited castration-resistant
prostate cancer cells proliferation and invasion via AKT/mTOR
signal pathway. Biomed Res Int. 2017:25936742017.PubMed/NCBI
|
|
10
|
Liu B, Zhou Y, Lu D, Liu Y, Zhang SQ, Xu
Y, Li W and Gu X: Comparison of the protein expression of
calpain-1, calpain-2, calpastatin and calmodulin between gastric
cancer and normal gastric mucosa. Oncol Lett. 14:3705–3710. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li ST, Chen NN, Qiao YB, Zhu WL, Ruan JW
and Zhou XZ: SC79 rescues osteoblasts from dexamethasone though
activating Akt-Nrf2 signaling. Biochem Biophys Res Commun.
479:54–60. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou J, Chang M, Li J, Fang T, Hu J and
Bai C: Knockdown of annexin A5 restores gefitinib sensitivity by
promoting G2/M cell cycle arrest. Respir Res. 19:962018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Storr SJ, Safuan S, Woolston CM,
Abdel-Fatah T, Deen S, Chan SY and Martin SG: Calpain-2 expression
is associated with response to platinum based chemotherapy,
progression-free and overall survival in ovarian cancer. J Cell Mol
Med. 16:2422–2428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang M, Hu J, Fang T, Li J, Song Y, Bai C
and Zhou J: PLIN2 confers gefitinib resistance by inhibiting cell
apoptosis via activation of EGFR/AKT/survivin in PC9R cells.
Oncotarget. Jan 10–2018.(Epub ahead of print). doi:
10.18632/oncotarget.24153.
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oliver FJ, de la Rubia G, Rolli V,
Ruiz-Ruiz MC, de Murcia G and Murcia JM: Importance of
poly(ADP-ribose) polymerase and its cleavage in apoptosis: Lesson
from an uncleavable mutant. J Biol Chem. 273:33533–33539. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okamoto K, Okamoto I, Hatashita E, Kuwata
K, Yamaguchi H, Kita A, Yamanaka K, Ono M and Nakagawa K:
Overcoming erlotinib resistance in EGFR mutation-positive non-small
cell lung cancer cells by targeting survivin. Mol Cancer Ther.
11:204–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okamoto K, Okamoto I, Okamoto W, Tanaka K,
Takezawa K, Kuwata K, Yamaguchi H, Nishio K and Nakagawa K: Role of
survivin in EGFR inhibitor-induced apoptosis in non-small cell lung
cancers positive for EGFR mutations. Cancer Res. 70:10402–10410.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miao C, Liang C, Tian Y, Xu A, Zhu J, Zhao
K, Zhang J, Hua Y, Liu S, Dong H, et al: Overexpression of CAPN2
promotes cell metastasis and proliferation via AKT/mTOR signaling
in renal cell carcinoma. Oncotarget. 8:97811–97821. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jacobsen K, Bertran-Alamillo J, Molina MA,
Teixidó C, Karachaliou N, Pedersen MH, Castellví J, Garzón M,
Codony-Servat C, Codony-Servat J, et al: Convergent Akt activation
drives acquired EGFR inhibitor resistance in lung cancer. Nat
Commun. 8:4102017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lim W, Yang C, Jeong M, Bazer FW and Song
G: Coumestrol induces mitochondrial dysfunction by stimulating ROS
production and calcium ion influx into mitochondria in human
placental choriocarcinoma cells. Mol Hum Reprod. 23:786–802. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sivalingam KS, Paramasivan P, Weng CF and
Viswanadha VP: Neferine potentiates the antitumor effect of
cisplatin in human lung adenocarcinoma cells Via a
mitochondria-mediated apoptosis pathway. J Cell Biochem.
118:2865–2876. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Losuwannarak N, Sritularak B and
Chanvorachote P: Cycloartobiloxanthone induces human lung cancer
cell apoptosis via mitochondria-dependent apoptotic pathway. In
Vivo. 32:71–78. 2018.PubMed/NCBI
|
|
24
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clinic Proc. 83:584–594.
2008. View Article : Google Scholar
|
|
25
|
Wang B, Jiang H, Wang L, Chen X, Wu K,
Zhang S, Ma S and Xia B: Increased MIR31HG lncRNA expression
increases gefitinib resistance in non-small cell lung cancer cell
lines through the EGFR/PI3K/AKT signaling pathway. Oncol Lett.
13:3494–3500. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rock JR, Onaitis MW, Rawlins EL, Lu Y,
Clark CP, Xue Y, Randell SH and Hogan BL: Basal cells as stem cells
of the mouse trachea and human airway epithelium. Proc Natl Acad
Sci USA. 106:12771–12775. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zuo W, Zhang T, Wu DZ, Guan SP, Liew AA,
Yamamoto Y, Wang X, Lim SJ, Vincent M, Lessard M, et al:
p63+Krt5+ distal airway stem cells are
essential for lung regeneration. Nature. 517:616–620. 2015.
View Article : Google Scholar : PubMed/NCBI
|
